More recently, Cichowski and colleagues elegantly showed that loss of DAB2IP triggers the production of inflammatory mediators and the onset of a pro-tumorigenic immune microenvironment in KRAS-mutant colon cancer [20]. The gene discussed is DAB2IP; the disease is malignant colon neoplasm.